| CTRI Number |
CTRI/2025/12/098277 [Registered on: 01/12/2025] Trial Registered Prospectively |
| Last Modified On: |
20/11/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
A study to see whether a commonly used sedative medicine dexmedetomidine can safely increase the duration of spinal anaesthesia in patients undergoing lower abdominal surgery |
|
Scientific Title of Study
|
Effect of intravenous dexmedetomidine on duration of spinal anaesthesia with hyperbaric bupivacaine in patients undergoing lower abdominal surgeries |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
VARSHINI R V |
| Designation |
Postgraduate Resident |
| Affiliation |
PSG Institute of Medical Sciences and Research |
| Address |
Department of Anaesthesiology, A Block, PSG Institute of medical sciences, Avinashi Road, Peelamedu, Coimbatore, Tamilnadu 641 004.
Coimbatore TAMIL NADU 641004 India |
| Phone |
9994412828 |
| Fax |
|
| Email |
varshadevi.v@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DHANABAGYAM G |
| Designation |
Professor |
| Affiliation |
PSG Institute of Medical Sciences and Research |
| Address |
Department of Anaesthesiology, A Block, PSG Institute of Medical sciences and research, Avinashi Road, Peelamedu, Coimbatore, Tamilnadu 641 004.
Coimbatore TAMIL NADU 641004 India |
| Phone |
99944 44245 |
| Fax |
|
| Email |
red.sparks100@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
VARSHINI R V |
| Designation |
Postgraduate Resident |
| Affiliation |
PSG Institute of Medical Sciences and Research |
| Address |
Department of Anaesthesiology, A Block, PSG Institute of Medical Sciences and Research, Avinashi Road, Peelamedu, Coimbatore, Tamilnadu 641 004.
Coimbatore TAMIL NADU 641004 India |
| Phone |
9994412828 |
| Fax |
|
| Email |
varshadevi.v@gmail.com |
|
|
Source of Monetary or Material Support
|
| PSG Institute of Medical Sciences and Research |
|
|
Primary Sponsor
|
| Name |
VARSHINI R V |
| Address |
PSG Institute of Medical Sciences and Research, Avinashi road, Peelamedu, Coimbatore, Tamilnadu 641004 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| VARSHINI R V |
PSG Institute of Medical Sciences and Research |
Department of Anaesthesiology, Operation Theatre Complex, A Block. Coimbatore TAMIL NADU |
9994412828
varshadevi.v@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL HUMAN ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Dexmedetomidine |
Intravenous dexmedetomidine 0.5microgram/kg in 100ml normal saline as bolus dose, ten minutes prior to subarachnoid block with Bupivacaine. |
| Comparator Agent |
Normal saline |
100ml of normal saline as bolus dose, ten minutes prior to subarachnoid block with Bupivacaine
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients admitted for Elective lower abdominal surgeries under spinal anaesthesia with ASA grades 1 and 2
|
|
| ExclusionCriteria |
| Details |
Patient refusal Contraindications to regional anaesthesia Patients with hepatic and renal impairment Patients taking Beta blockers and steroids |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Duration of sensory block motor block and analgesia in spinal anaesthesia |
Intraoperative period and postoperative period until full recovery of sensory and motor function up to 4 hours post spinal anaesthesia |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Hemodynamic parameters Level of sedation and Adverse effects in spinal anaesthesia |
Intraoperative period and postoperative period until full recovery of sensory and motor function up to 4 hours post spinal anaesthesia |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
03/12/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="8" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This prospective double blinded randomized controlled study evaluates the effect of intravenous dexmedetomidine on the duration and quality of spinal anaesthesia with hyperbaric bupivacaine in patients undergoing lower abdominal surgeries. Sixty patients belonging to ASA I and II aged 18 to 60 years are randomly divided into two groups one receiving IV dexmedetomidine and the other normal saline before spinal block. The study compares sensory and motor block duration analgesia hemodynamic stability sedation and adverse effects between two groups. The aim is to determine whether IV dexmedetomidine safely enhances spinal block duration and improves patient comfort and recovery. |